The StartUp & ScaleUp Centers provide private, secured laboratories for early-stage companies ranging from 100 – 3,000 SF. The facility soft-opened on June 15th and is already home to 17 companies and over 40 employees. The project was a partnership with the Commonwealth of Massachusetts and funded with a $3.5 million MLSC Capital Grant.
The gathering will also serve as an opportunity for an exciting update relative to the MLSC’s Seed Fund program. The Seed Fund’s mission is to advance innovative and promising life science companies in targeted geographies throughout the Commonwealth by working with partners to leverage resources and promote economic development.
MBI, the longest-running life sciences incubator in the Commonwealth, is currently home to over 50 companies and has graduated almost 100 companies, which employ over 800 in the local life sciences cluster.
Unless otherwise specifically stated in relation to each and any of the events listed on this page, the MLSC does not host or sponsor these events. The MLSC has no oversight or responsibility for the venue, content or host-organization related to these events. The MLSC has no affiliation with the organizations listing events or with the events, and provides this content and information as a convenience to visitors to the MLSC website.
Olaris is a precision diagnostics company that is on a mission to revolutionize how diseases are diagnosed and treated. By leveraging their CEREBRO platform (Comprehensive Early Responsive Evaluation of Biomarkers Related to Outcomes), which combines metabolomics and machine learning, they are able to harness the power of the body’s own communication system to discover and develop their pipeline of myOLARIS precision diagnostics.